Gene network signaling in hormone responsiveness modifies apoptosis and autophagy in breast cancer cells

Resistance to endocrine therapies, whether de novo or acquired, remains a major limitation in the ability to cure many tumors that express detectable levels of the estrogen receptor alpha protein (ER). While several resistance phenotypes have been described, endocrine unresponsiveness in the context of therapy-induced tumor growth appears to be the most prevalent. The signaling that regulates endocrine resistant phenotypes is poorly understood but it involves a complex signaling network with a topology that includes redundant and degenerative features. To be relevant to clinical outcomes, the most pertinent features of this network are those that ultimately affect the endocrine-regulated components of the cell fate and cell proliferation machineries. We show that autophagy, as supported by the endocrine regulation of monodansylcadaverine staining, increased LC3 cleavage, and reduced expression of p62/SQSTM1, plays an important role in breast cancer cells responding to endocrine therapy. We further show that the cell fate machinery includes both apoptotic and autophagic functions that are potentially regulated through integrated signaling that flows through key members of the BCL2 gene family and beclin-1 (BECN1). This signaling links cellular functions in mitochondria and endoplasmic reticulum, the latter as a consequence of induction of the unfolded protein response. We have taken a seed-gene approach to begin extracting critical nodes and edges that represent central signaling events in the endocrine regulation of apoptosis and autophagy. Three seed nodes were identified from global gene or protein expression analyses and supported by subsequent functional studies that established their abilities to affect cell fate. The seed nodes of nuclear factor kappa B (NFkappaB), interferon regulatory factor-1 (IRF1), and X-box binding protein-1 (XBP1)are linked by directional edges that support signal flow through a preliminary network that is grown to include key regulators of their individual function: NEMO/IKKgamma, nucleophosmin and ER respectively. Signaling proceeds through BCL2 gene family members and BECN1 ultimately to regulate cell fate.

[1]  A. Howell,et al.  Response to a specific antioestrogen (ICI 182780) in tamoxifen-resistant breast cancer , 1995, The Lancet.

[2]  I. Todd,et al.  A New Anti-oestrogenic Agent in Late Breast Cancer: An Early Clinical Appraisal of ICI46474 , 1971, British Journal of Cancer.

[3]  Robert Clarke,et al.  Antiestrogens, aromatase inhibitors, and apoptosis in breast cancer. , 2005, Vitamins and hormones.

[4]  D. J. Jerry,et al.  Sensitivity to DNA Damage Is a Common Component of Hormone-Based Strategies for Protection of the Mammary Gland , 2005, Molecular Cancer Research.

[5]  S. Cummings,et al.  The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation. , 1999, JAMA.

[6]  T. Mizushima,et al.  Structural Basis for Sorting Mechanism of p62 in Selective Autophagy* , 2008, Journal of Biological Chemistry.

[7]  Keiji Tanaka,et al.  Selective turnover of p62/A170/SQSTM1 by autophagy , 2008, Autophagy.

[8]  D. Ron,et al.  Translational control in the endoplasmic reticulum stress response. , 2002, The Journal of clinical investigation.

[9]  C. Thompson,et al.  Death by design: apoptosis, necrosis and autophagy. , 2004, Current opinion in cell biology.

[10]  N. Brünner,et al.  Cross-resistance and molecular mechanisms in antiestrogen resistance , 1995 .

[11]  W. Funkhouser,et al.  Selective activation of NF-κB subunits in human breast cancer: potential roles for NF-κB2/p52 and for Bcl-3 , 2000, Oncogene.

[12]  I. Roninson,et al.  If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells. , 2001, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[13]  Hong Liu,et al.  Paradoxical action of fulvestrant in estradiol-induced regression of tamoxifen-stimulated breast cancer. , 2003, Journal of the National Cancer Institute.

[14]  John L Cleveland,et al.  Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes , 2008, Autophagy.

[15]  R. Clarke,et al.  Cellular and molecular pharmacology of antiestrogen action and resistance. , 2001, Pharmacological reviews.

[16]  Philippe Dessen,et al.  Inhibition of Macroautophagy Triggers Apoptosis , 2005, Molecular and Cellular Biology.

[17]  R. Clarke,et al.  Approaches to working in high-dimensional data spaces: gene expression microarrays , 2008, British Journal of Cancer.

[18]  K. Mori,et al.  XBP1: a link between the unfolded protein response, lipid biosynthesis, and biogenesis of the endoplasmic reticulum. , 2004, The Journal of cell biology.

[19]  M. Lynch,et al.  Recombinant human interferon alpha increases oestrogen receptor expression in human breast cancer cells (ZR-75-1) and sensitizes them to the anti-proliferative effects of tamoxifen. , 1987, British Journal of Cancer.

[20]  M. Merville,et al.  Nuclear factor-kappa B, cancer, and apoptosis. , 2000, Biochemical pharmacology.

[21]  K. Becker,et al.  NF kappa B and interferon regulatory factor 1 physically interact and synergistically induce major histocompatibility class I gene expression. , 1995, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[22]  G. Giaccone,et al.  Cell Death Independent of Caspases: A Review , 2005, Clinical Cancer Research.

[23]  Robert Clarke,et al.  Interferon regulatory factor-1 (IRF-1) exhibits tumor suppressor activities in breast cancer associated with caspase activation and induction of apoptosis. , 2005, Carcinogenesis.

[24]  R. Clarke,et al.  The inter-relationships between ovarian-independent growth, tumorigenicity, invasiveness and antioestrogen resistance in the malignant progression of human breast cancer. , 1989, The Journal of endocrinology.

[25]  Geert J. P. L. Kops,et al.  On the road to cancer: aneuploidy and the mitotic checkpoint , 2005, Nature Reviews Cancer.

[26]  Craig B. Thompson,et al.  Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes , 2004, Nature Cell Biology.

[27]  N. Mizushima,et al.  How to Interpret LC3 Immunoblotting , 2007, Autophagy.

[28]  A. Jemal,et al.  Cancer Statistics, 2006 , 2006, CA: a cancer journal for clinicians.

[29]  R. Dickson,et al.  Growth factors in breast cancer. , 1995, Endocrine reviews.

[30]  A. H. Harkness,et al.  Oral penicillin in gonorrhoea. , 1946, Lancet.

[31]  J. Forbes,et al.  A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer. , 2005, The New England journal of medicine.

[32]  M. Niwa,et al.  Intrinsic capacities of molecular sensors of the unfolded protein response to sense alternate forms of endoplasmic reticulum stress. , 2006, Molecular biology of the cell.

[33]  Neal N. Iwakoshi,et al.  Plasma cell differentiation requires the transcription factor XBP-1 , 2001, Nature.

[34]  C. Lowenstein,et al.  Interaction of interferon regulatory factor-1 and nuclear factor kappaB during activation of inducible nitric oxide synthase transcription. , 1999, Journal of molecular biology.

[35]  P. Lønning,et al.  Cognitive ability in childhood and cognitive decline in mid-life: longitudinal birth cohort study , 2003, BMJ : British Medical Journal.

[36]  M. Glimcher,et al.  In situ hybridization studies suggest a role for the basic region‐leucine zipper protein hXBP‐1 in exocrine gland and skeletal development during mouse embryogenesis , 1993, Developmental dynamics : an official publication of the American Association of Anatomists.

[37]  P. Rudland,et al.  Expression and splicing of the unfolded protein response gene XBP‐1 are significantly associated with clinical outcome of endocrine‐treated breast cancer , 2008, International journal of cancer.

[38]  N. Kyprianou,et al.  Apoptosis evasion: The role of survival pathways in prostate cancer progression and therapeutic resistance , 2006, Journal of cellular biochemistry.

[39]  J Lippman,et al.  MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen. , 1997, Cancer research.

[40]  R. Gray,et al.  Survival advantage of adjuvant chemotherapy in high-risk node-negative breast cancer: ten-year analysis--an intergroup study. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[41]  C. Boni,et al.  Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[42]  T. Taniguchi,et al.  Loss of transcription factor IRF-1 affects tumor susceptibility in mice carrying the Ha-ras transgene or nullizygosity for p53. , 1999, Genes & development.

[43]  R. Clarke,et al.  Acquired estrogen independence and antiestrogen resistance in breast cancer Estrogen receptor driven phenotypes? , 1996, Trends in Endocrinology & Metabolism.

[44]  P. Clarke,et al.  Autophagy Can Be a Killer Even in Apoptosis-Competent Cells , 2006, Autophagy.

[45]  R. Murphy,et al.  Reduction of the membrane fluidity of human breast cancer cells by tamoxifen and 17 beta-estradiol. , 1990, Journal of the National Cancer Institute.

[46]  T. Motyl,et al.  BID-Deficient Breast Cancer MCF-7 Cells as a Model for the Study of Autophagy in Cancer Therapy , 2006, Autophagy.

[47]  G. Doherty,et al.  The role of interferon regulatory factor-1 and interferon regulatory factor-2 in IFN-gamma growth inhibition of human breast carcinoma cell lines. , 2003, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[48]  G. Schulz,et al.  Structure of the thiamine- and flavin-dependent enzyme pyruvate oxidase , 1993, Science.

[49]  H. Hibshoosh,et al.  Induction of autophagy and inhibition of tumorigenesis by beclin 1 , 1999, Nature.

[50]  Robert Clarke,et al.  Estrogen receptor alpha positive breast tumors and breast cancer cell lines share similarities in their transcriptome data structures. , 2006, International journal of oncology.

[51]  T. Taniguchi,et al.  Identification and characterization of nucleophosmin/B23/numatrin which binds the anti-oncogenic transcription factor IRF-1 and manifests oncogenic activity , 1997, Oncogene.

[52]  G. Kroemer,et al.  Apoptosis and genomic instability , 2004, Nature Reviews Molecular Cell Biology.

[53]  Debajit K. Biswas,et al.  Epidermal growth factor-induced nuclear factor κB activation: A major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells , 2000 .

[54]  Wei Zhang,et al.  Interferon regulatory factor-1 (IRF-1) is a mediator for interferon-γ induced attenuation of telomerase activity and human telomerase reverse transcriptase (hTERT) expression , 2003, Oncogene.

[55]  S. Perea,et al.  Activation of the Human p27Kip1 Promoter by IFNα 2b , 2000 .

[56]  R. Clarke,et al.  Interferon Regulatory Factor-1 Mediates the Proapoptotic but Not Cell Cycle Arrest Effects of the Steroidal Antiestrogen ICI 182,780 (Faslodex, Fulvestrant) , 2004, Cancer Research.

[57]  C. Osborne,et al.  Human breast cancer in the athymic nude mouse: cytostatic effects of long-term antiestrogen therapy. , 1987, European journal of cancer & clinical oncology.

[58]  E. Paterson,et al.  SYNTHETIC ŒSTROGENS IN MAMMARY CANCER , 1949 .

[59]  W. Bursch,et al.  Active cell death induced by the anti-estrogens tamoxifen and ICI 164 384 in human mammary carcinoma cells (MCF-7) in culture: the role of autophagy. , 1996, Carcinogenesis.

[60]  R. Fulthorpe,et al.  Identification of estrogen-responsive genes by complementary deoxyribonucleic acid microarray and characterization of a novel early estrogen-induced gene: EEIG1. , 2004, Molecular endocrinology.

[61]  R. Clarke,et al.  Molecular and pharmacological aspects of antiestrogen resistance , 2001, The Journal of Steroid Biochemistry and Molecular Biology.

[62]  Alberto de la Fuente,et al.  Discovery of meaningful associations in genomic data using partial correlation coefficients , 2004, Bioinform..

[63]  N. Brünner,et al.  Two-dimensional gel electrophoresis analyses identify nucleophosmin as an estrogen regulated protein associated with acquired estrogen-independence in human breast cancer cells , 1998, The Journal of Steroid Biochemistry and Molecular Biology.

[64]  J. Cuzick,et al.  Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early‐stage breast cancer , 2003, Cancer.

[65]  A. Haddow,et al.  Influence of Synthetic Oestrogens on Advanced Malignant Disease , 1944, British medical journal.

[66]  Marcel Leist,et al.  Cell Death: Apoptosis versus Necrosis , 1997 .

[67]  S. Gorski,et al.  Macroautophagy inhibition sensitizes tamoxifen-resistant breast cancer cells and enhances mitochondrial depolarization , 2008, Breast Cancer Research and Treatment.

[68]  Robert Clarke,et al.  Expression patterns among interferon regulatory factor-1, human X-box binding protein-1, nuclear factor kappa B, nucleophosmin, estrogen receptor-alpha and progesterone receptor proteins in breast cancer tissue microarrays. , 2006, International journal of oncology.

[69]  S. Pattingre,et al.  The Evolutionarily Conserved Domain of Beclin 1 is Required for Vps34 Binding, Autophagy, and Tumor Suppressor Function , 2005, Autophagy.

[70]  R. Clarke,et al.  Human X‐Box binding protein‐1 confers both estrogen independence and antiestrogen resistance in breast cancer cell lines , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[71]  Michael D. Schneider,et al.  Bcl-2 Antiapoptotic Proteins Inhibit Beclin 1-Dependent Autophagy , 2005, Cell.

[72]  Michael L. Bittner,et al.  Growing genetic regulatory networks from seed genes , 2004, Bioinform..

[73]  G. Kroemer,et al.  Mitotic catastrophe constitutes a special case of apoptosis whose suppression entails aneuploidy , 2004, Oncogene.

[74]  S. Cosimo,et al.  Second- and third-generation aromatase inhibitors as first-line endocrine therapy in postmenopausal metastatic breast cancer patients: a pooled analysis of the randomised trials , 2006, British Journal of Cancer.

[75]  Luciana Dini,et al.  Cell death: apoptosis versus necrosis (review). , 2002, International journal of oncology.

[76]  J. Shay,et al.  Reversible cellular senescence: implications for immortalization of normal human diploid fibroblasts , 1989, Molecular and cellular biology.

[77]  J. Yee,et al.  The IFN Regulatory Factor Family Participates in Regulation of Fas Ligand Gene Expression in T Cells , 2000, The Journal of Immunology.

[78]  C. Watson,et al.  NF-kappaB and Apoptosis in Mammary Epithelial Cells , 1999, Journal of Mammary Gland Biology and Neoplasia.

[79]  al. et,et al.  Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia , 1993, Science.

[80]  S. Vacher,et al.  Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach. , 2006, Endocrine-related cancer.

[81]  J. Russo,et al.  Activation of NF-kappaB/Rel occurs early during neoplastic transformation of mammary cells. , 2000, Carcinogenesis.

[82]  W. Doppler,et al.  An essential link to mammary cancer? , 2002, Nature Medicine.

[83]  Michelle L Bowie,et al.  Interferon-regulatory factor-1 is critical for tamoxifen-mediated apoptosis in human mammary epithelial cells , 2004, Oncogene.

[84]  A. Porter,et al.  Mifepristone Induces Growth Arrest, Caspase Activation, and Apoptosis of Estrogen Receptor-Expressing, Antiestrogen-Resistant Breast Cancer Cells , 2004, Clinical Cancer Research.

[85]  P. Fisher,et al.  PERK-dependent regulation of MDA-7/IL-24-induced autophagy in primary human glioma cells , 2008, Autophagy.

[86]  K. Mori,et al.  XBP1 mRNA Is Induced by ATF6 and Spliced by IRE1 in Response to ER Stress to Produce a Highly Active Transcription Factor , 2001, Cell.

[87]  Yongqiang Chen,et al.  Oxidative stress induces autophagic cell death independent of apoptosis in transformed and cancer cells , 2008, Cell Death and Differentiation.

[88]  A. Sahin,et al.  Tissue transglutaminase-induced alterations in extracellular matrix inhibit tumor invasion , 2005, Molecular Cancer.

[89]  L. Attardi,et al.  The role of apoptosis in cancer development and treatment response , 2005, Nature Reviews Cancer.

[90]  Shin Namiki,et al.  IRF‐1 mediates upregulation of LMP7 by IFN‐γ and concerted expression of immunosubunits of the proteasome , 2005, FEBS letters.

[91]  O. Olopade,et al.  Estrogen Receptor Status in BRCA1- and BRCA2-Related Breast Cancer , 2004, Clinical Cancer Research.

[92]  Z. Qin,et al.  Autophagy is involved in cytotoxic effects of crotoxin in human breast cancer cell line MCF-7 cells , 2007, Acta Pharmacologica Sinica.

[93]  C. Redmond,et al.  Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of findings from NSABP B-19 comparing methotrexate and , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[94]  Norman Wolmark,et al.  Estrogen receptor status of primary breast cancer is predictive of estrogen receptor status of contralateral breast cancer. , 2004, Journal of the National Cancer Institute.

[95]  K. Suk,et al.  Interferon gamma (IFNgamma ) and tumor necrosis factor alpha synergism in ME-180 cervical cancer cell apoptosis and necrosis. IFNgamma inhibits cytoprotective NF-kappa B through STAT1/IRF-1 pathways. , 2001, The Journal of biological chemistry.

[96]  Mike Clarke,et al.  Polychemotherapy for early breast cancer: an overview of the randomised trials , 1998, The Lancet.

[97]  L. Glimcher,et al.  The basic domain/leucine zipper protein hXBP-1 preferentially binds to and transactivates CRE-like sequences containing an ACGT core. , 1996, Nucleic acids research.

[98]  M. E. El Etreby,et al.  Additive effect of mifepristone and tamoxifen on apoptotic pathways in MCF-7 human breast cancer cells , 1998, Breast Cancer Research and Treatment.

[99]  T. Taniguchi,et al.  An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes , 1995, Nature.

[100]  R. Kaufman,et al.  The unfolded protein response , 2006, Neurology.

[101]  M. Mann,et al.  Identification of the receptor component of the IκBα–ubiquitin ligase , 1998, Nature.

[102]  M. Dowsett,et al.  Reduced apoptosis and proliferation and increased Bcl-2 in residual breast cancer following preoperative chemotherapy , 1998, Breast Cancer Research and Treatment.

[103]  T. Taniguchi,et al.  Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development , 1993, Cell.

[104]  Simon C Watkins,et al.  Ectopic Expression of Interferon Regulatory Factor-1 Promotes Human Breast Cancer Cell Death and Results in Reduced Expression of Survivin , 2004, Cancer Research.

[105]  R Clarke,et al.  Progression of human breast cancer cells from hormone-dependent to hormone-independent growth both in vitro and in vivo. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[106]  S. Pattingre,et al.  Bcl-2 inhibition of autophagy: a new route to cancer? , 2006, Cancer research.

[107]  A. Fojo,et al.  Acquisition of hormone-independent growth in MCF-7 cells is accompanied by increased expression of estrogen-regulated genes but without detectable DNA amplifications. , 1993, Cancer research.

[108]  W. Tam,et al.  IκB Family Members Function by Different Mechanisms* , 2001, The Journal of Biological Chemistry.

[109]  Mike Clarke,et al.  Tamoxifen for early breast cancer: an overview of the randomised trials , 1998, The Lancet.

[110]  Michael Karin,et al.  NF-κB in cancer: from innocent bystander to major culprit , 2002, Nature Reviews Cancer.

[111]  S. Orkin,et al.  An essential role in liver development for transcription factor XBP-1. , 2000, Genes & development.

[112]  Robert Clarke,et al.  Motif-directed network component analysis for regulatory network inference , 2008, BMC Bioinformatics.

[113]  S. Thorpe Estrogen and progesterone receptor determinations in breast cancer. Technology, biology and clinical significance. , 1988, Acta oncologica.

[114]  A. Howell,et al.  Fulvestrant, formerly ICI 182,780, is as effective as anastrozole in postmenopausal women with advanced breast cancer progressing after prior endocrine treatment. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[115]  Timothy R Billiar,et al.  IRF-1 expression induces apoptosis and inhibits tumor growth in mouse mammary cancer cells in vitro and in vivo , 2004, Oncogene.

[116]  A. Apel,et al.  Blocked autophagy sensitizes resistant carcinoma cells to radiation therapy. , 2008, Cancer research.

[117]  D. Cameron,et al.  Effective tamoxifen therapy of breast cancer involves both antiproliferative and pro-apoptotic changes. , 2000, European journal of cancer.

[118]  N. Zeleznik-Le,et al.  A new member of the leucine zipper class of proteins that binds to the HLA DR alpha promoter. , 1990, Science.

[119]  T. Hofmann,et al.  The Antiinflammatory Sesquiterpene Lactone Parthenolide Inhibits NF-κB by Targeting the IκB Kinase Complex , 1999, The Journal of Immunology.

[120]  Robert Clarke,et al.  Estrogen Withdrawal-Induced NF-κB Activity and Bcl-3 Expression in Breast Cancer Cells: Roles in Growth and Hormone Independence , 2003, Molecular and Cellular Biology.

[121]  A. Kimchi,et al.  DAP kinase and DRP-1 mediate membrane blebbing and the formation of autophagic vesicles during programmed cell death , 2002, The Journal of cell biology.

[122]  N. Brünner,et al.  Association of interferon regulatory factor-1, nucleophosmin, nuclear factor-kappaB, and cyclic AMP response element binding with acquired resistance to Faslodex (ICI 182,780). , 2002, Cancer research.

[123]  T. Taniguchi,et al.  Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1 , 1994, Cell.

[124]  V. Jordan,et al.  Development of tamoxifen-stimulated growth of MCF-7 tumors in athymic mice after long-term antiestrogen administration. , 1988, Cancer research.

[125]  Thomas Schaffner,et al.  Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis , 2006, Nature Cell Biology.

[126]  S. Huang,et al.  Genomics, complexity and drug discovery: insights from Boolean network models of cellular regulation. , 2001, Pharmacogenomics.

[127]  Anthony Howell,et al.  Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group. , 1992 .

[128]  G. Gao,et al.  Autophagy protects LNCaP cells under androgen deprivation conditions , 2008, Autophagy.

[129]  D. Harrison,et al.  Altered DNA repair and dysregulation of p53 in IRF‐1 null hepatocytes , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[130]  M. Mesiti,et al.  Sequential tamoxifen and aminoglutethimide versus tamoxifen alone in the adjuvant treatment of postmenopausal breast cancer patients: results of an Italian cooperative study. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[131]  Arul M Chinnaiyan,et al.  Genes regulated by estrogen in breast tumor cells in vitro are similarly regulated in vivo in tumor xenografts and human breast tumors , 2006, Genome Biology.

[132]  Y. Nomura,et al.  Differential effects of estrogen and antiestrogen on in vitro clonogenic growth of human breast cancers in soft agar. , 1990, Journal of the National Cancer Institute.

[133]  Gerard I. Evan,et al.  The coordinate release of cytochrome c during apoptosis is rapid, complete and kinetically invariant , 2000, Nature Cell Biology.

[134]  R. Clarke,et al.  MCF7/LCC2: a 4-hydroxytamoxifen resistant human breast cancer variant that retains sensitivity to the steroidal antiestrogen ICI 182,780. , 1993, Cancer research.

[135]  P. Fisher,et al.  Caspase-, cathepsin-, and PERK-dependent regulation of MDA-7/IL-24-induced cell killing in primary human glioma cells , 2008, Molecular Cancer Therapeutics.

[136]  Robert Clarke,et al.  Network motif-based identification of transcription factor-target gene relationships by integrating multi-source biological data , 2008, BMC Bioinformatics.

[137]  Q. Ye,et al.  Ligand‐independent activation of estrogen receptor α by XBP‐1 , 2003 .

[138]  R. Clarke,et al.  The A4396G polymorphism in interferon regulatory factor 1 is frequently expressed in breast cancer cell lines. , 2007, Cancer genetics and cytogenetics.

[139]  C Roskelley,et al.  A biomarker that identifies senescent human cells in culture and in aging skin in vivo. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[140]  G. Sledge,et al.  Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth , 1997, Molecular and cellular biology.

[141]  T. Noda,et al.  Dissection of the Autophagosome Maturation Process by a Novel Reporter Protein, Tandem Fluorescent-Tagged LC3 , 2007, Autophagy.

[142]  Ian B. Jeffery,et al.  Integrating transcription factor binding site information with gene expression datasets , 2007, Bioinform..

[143]  Nuclear Factor-kappa B , 2006 .

[144]  B. Trock,et al.  Autoantibodies to the Nucleolar Phosphoprotein Nucleophosmin in Breast Cancer Patients , 1998 .

[145]  A. Koong,et al.  The Unfolded Protein Response: A Novel Component of the Hypoxic Stress Response in Tumors , 2005, Molecular Cancer Research.

[146]  Robert B Livingston,et al.  Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17. , 2005, Journal of the National Cancer Institute.

[147]  Robert Clarke,et al.  Knowledge-guided multi-scale independent component analysis for biomarker identification , 2008, BMC Bioinformatics.

[148]  Michael Gnant,et al.  Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial , 2005, The Lancet.

[149]  F. Urano,et al.  Autophagy Is Activated for Cell Survival after Endoplasmic ReticulumStress , 2006, Molecular and Cellular Biology.

[150]  Minetta C. Liu,et al.  Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling , 2003, Oncogene.

[151]  Terje Johansen,et al.  p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death , 2005, The Journal of cell biology.

[152]  S. Glück Anastrozole Is Superior to Tamoxifen as First-Line Therapy in Hormone Receptor Positive Advanced Breast Carcinoma Results of Two Randomized Trials Designed for Combined Analysis , 2001 .

[153]  Neal N. Iwakoshi,et al.  Proteasome inhibitors disrupt the unfolded protein response in myeloma cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[154]  T. Taniguchi,et al.  Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage , 1996, Nature.

[155]  T. Reimer,et al.  Tumour Fas ligand:Fas ratio greater than 1 is an independent marker of relative resistance to tamoxifen therapy in hormone receptor positive breast cancer , 2002, Breast Cancer Research.

[156]  Jung-whan Kim,et al.  IFN‐γ/IRF‐1‐induced p27 kip1 down‐regulates telomerase activity and human telomerase reverse transcriptase expression in human cervical cancer , 2005 .

[157]  O. Delattre,et al.  IFN-β induces serine phosphorylation of Stat-1 in Ewing's sarcoma cells and mediates apoptosis via induction of IRF-1 and activation of caspase-7 , 2000, Oncogene.

[158]  Shengkan Jin Autophagy, Mitochondrial Quality Control, and Oncogenesis , 2006, Autophagy.

[159]  E. Gehan,et al.  The properties of high-dimensional data spaces: implications for exploring gene and protein expression data , 2008, Nature Reviews Cancer.

[160]  W. Foulkes Re: Estrogen receptor status of primary breast cancer is predictive of estrogen receptor status of contralateral breast cancer. , 2004, Journal of the National Cancer Institute.